OxyContin marketer agrees to pay $350 million rather than face lawsuits
A company that helped develop marketing campaigns for OxyContin and other opioids has agreed to a $350 million settlement.
A company that helped develop marketing campaigns for OxyContin and other opioids has agreed to a $350 million settlement.